Company Profile
Asahi Kasei Corporation engages in material, homes, and healthcare businesses in Japan, the United States, China, and internationally. The company offers Pimel, a photosensitive PI material applied for semiconductor applications, such as buffer coating, passivation layers, and dielectric layers; Sunfort, a dry film photoresist; Novacure, a latent curing agent for epoxy resin; glass fabric for printed circuit boards; plastic optical fiber; sensors and devices; artificial suede products under the Dinamica name; Microza UF and MF industrial membranes and systems; Aciplex membranes, process equipment, and systems for caustic soda production; alkaline water electrolyzer for producing hydrogen from renewable energy Aqualyzer; Hipore, a microporous polyolefin sheet which prevents the anode and cathode; Celgard, a lithium-ion battery separator; photopolymers and platemaking systems; and fiber products under the Bemberg, Bemliese, NanoAct, and ROICA names. It also provides cling film, bags, and containers under the Saran Wrap, Ziploc, and Cookper names; packaging products under the Suntec, Barrialon, PVDC latex, and Saran fiber names; pharmaceutical and food additives under the Ceolous and Celphere names; and clads and anchors under the Baclad and AR Chemical Setter names. In addition, the company offers prescription drugs in the fields of orthopedics, critical/intensive care, urology, immune system, and central nervous system; virus removal filters; wearable defibrillators, temperature management systems, pre-hospital, and hospital data management systems; overseas homes, unit homes and apartment buildings, and real estate-related operations; autoclaved aerated concretes, foundation systems, thermal insulations, and structural systems and component products; polymers, monomers, foamed products, and cleaners; and synthetic rubber, elastomers, and intermediates and inorganic chemicals. Asahi Kasei Corporation was founded in 1922 and is headquartered in Chiyoda, Japan.
Latest News
Ipsen’s Bylvay fails in Phase III biliary atresia study
Rothschild & Co Redburn Adjusts PT on Honeywell International to $216 From $214, Keeps Neutral Rating
JPMorgan Adjusts PT on Honeywell International to $262 From $250, Maintains Overweight Rating
Jefferies Adjusts Price Target on Teledyne Technologies to $830 From $775, Maintains Buy Rating
Goldman Sachs Adjusts PT on Teledyne Technologies to $877 From $858, Maintains Buy Rating
| Sector | Industrials |
| Industry | Conglomerates |
| Website | https://www.asahi-kasei.com |
| Audit Risk | 1 |
| Board Risk | 4 |
| Overall Risk | 3 |
| Market Cap | 2.52T |
| Trailing P/E | 16 |
| Forward P/E | 18.68 |
| Dividend Rate | 44 |
| Dividend Yield | 2.38% |
| Trailing Annual Div. Rate | 42 |
| Trailing Annual Div. Yield | 2.28% |
| Trailing EPS | 117 |
| Forward EPS | 100.26 |
| Book Value | 1,539.66 |
| Price-to-Book | 1.22 |
| Enterprise-to-Revenue | 1.05 |
| Enterprise-to-EBITDA | 7.52 |
| Ex-Dividend Date | 09/29/2026 |
| Earnings Date | 07/31/2026 |
| Earnings Call Date | |
| Revenue Average | 817.88B |
| Revenue Low | 808.00B |
| Revenue High | 827.00B |